Pomerantz Roger has filed 15 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 30000 shares of Indaptus Therapeutics, Inc. ($INDP) on June 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Pomerantz Roger | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 12,013,901 | 9999.99% | 0.25% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Pomerantz Roger | Director | D | Stock Option (right to buy) | 500 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Pomerantz Roger | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Pomerantz Roger | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| Nov. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | M | Common Stock | 9034 | $0.00 | 126,478.0000 | 39,744,222 | 7.69% | 0.02% |
| Nov. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | M | Restricted Stock Units | 9034 | $0.00 | 18,069.0000 | 39,744,222 | 33.33% | 0.02% |
| Aug. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | M | Common Stock | 9034 | $0.00 | 117,444.0000 | 39,272,434 | 8.33% | 0.02% |
| Aug. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | M | Restricted Stock Units | 9034 | $0.00 | 27,103.0000 | 39,272,434 | 25.00% | 0.02% |
| June 20, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | A | Stock Option (Right to Buy) | 18750 | $0.00 | 18,750.0000 | 39,272,434 | 9999.99% | 0.05% |
| June 6, 2024 | Indaptus Therapeutics, Inc. | $INDP | Pomerantz Roger | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,401,047 | 9999.99% | 0.36% |
| May 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | M | Restricted Stock Units | 9035 | $0.00 | 36,137.0000 | 39,272,434 | 20.00% | 0.02% |
| May 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Not found | M | Common Stock | 9035 | $0.00 | 108,410.0000 | 39,272,434 | 9.09% | 0.02% |
| Feb. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Director | M | Restricted Stock Units | 9034 | $0.00 | 45,172.0000 | 0 | 16.67% | 0.00% |
| Feb. 25, 2024 | Viracta Therapeutics, Inc. | $VIRX | Pomerantz Roger | Director | M | Common Stock | 9034 | $0.00 | 99,375.0000 | 0 | 10.00% | 0.00% |